Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05762133 · ClinicalTrials.gov registry record · NA

African-American Social Support Effectiveness Treatment

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT05762133 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05762133, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The objective of this treatment study is to develop and test an augmentation therapy in conjunction with maternal psychiatric treatment that targets the fathers' support of the mothers' mental health and contributions to the family environment to reduce maternal stress. The African-American Social Support Effectiveness Treatment-Partners alleviating Perinatal Depression (ASSET-PPD) intervention will be delivered to fathers in an individual setting to target the context in which a mother lives to expand her support beyond the direct reach of her treatment professional. This study provides skills and training to fathers who have a partner with prenatal depression. The aim is to reduce maternal depression during the perinatal period and improve the family environment for the infant.

Interventions

  • BEHAVIORAL African-American Social Support Effectiveness Treatment-Partners alleviating Perinatal Depression (ASSET-PPD)

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-08-27
Est. Completion 2024-07-31
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT05762133

The ClinicalTrials.gov registry entry for NCT05762133 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which African-American Social Support Effectiveness Treatment-Partners alleviating Perinatal Depression (ASSET-PPD) is the first listed.

NCT05762133 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05762133 about?

NCT05762133 is a clinical study titled "African-American Social Support Effectiveness Treatment". The objective of this treatment study is to develop and test an augmentation therapy in conjunction with maternal psychiatric treatment that targets the fathers' support of the mothers' mental health and contributions to the family environment to reduce maternal stress. The African-American Social S...

What is the current status of trial NCT05762133?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-08-27. Estimated completion is 2024-07-31.

What interventions are being tested in trial NCT05762133?

The interventions under investigation include: African-American Social Support Effectiveness Treatment-Partners alleviating Perinatal Depression (ASSET-PPD) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05762133?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.